Minocycline and Isotretinoin Interaction
Drug interaction information between Minocycline and Isotretinoin.
Minocycline and Isotretinoin have a documented minor interaction in FDA labeling.
FDA drug labeling documents a minor-severity interaction between Minocycline and Isotretinoin. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.
How They Interact
Using these drugs together can increase the risk of dangerous pressure building up inside the skull.
What To Do
Do not take these two medications at the same time or within a short period of each other.
FDA Label Information
Administration of isotretinoin should be avoided shortly before, during, and shortly after minocycline therapy.
Isotretinoin Also Interacts With
- Progesterone major
- Retinol moderate
- Estradiol minor
- Norethindrone minor
- Phenytoin minor
Frequently Asked Questions
Can I take Minocycline and Isotretinoin together?
This is a minor interaction. Do not take these two medications at the same time or within a short period of each other.
How serious is the interaction between Minocycline and Isotretinoin?
This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.
Why do Minocycline and Isotretinoin interact?
Using these drugs together can increase the risk of dangerous pressure building up inside the skull.
Understanding the Minocycline and Isotretinoin Interaction
FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Minocycline belongs to the Tetracycline Antibiotic class and Isotretinoin belongs to the Systemic Retinoid class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Using these drugs together can increase the risk of dangerous pressure building up inside the skull. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.
Context around a specific patient determines real-world impact. Minocycline has 2 total documented interactions on file in this dataset, and Isotretinoin has 7. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Do not take these two medications at the same time or within a short period of each other. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.
An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Minocycline or Isotretinoin based on a web page, speak with your prescriber or pharmacist before making any change.
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.
Read our methodology - how this data is sourced, computed, and verified.